Small Lymphocytic Lymphoma (SLL) Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
2022-03-15
Mar 15, 2022
N
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
2022-03-25
Mar 25, 2022
M
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Venetoclax monotherapy
  • Venetoclax with anti CD20 monoclonal antibody
  • Basking Ridge, New Jersey
  • +9 more
2022-03-15
Mar 15, 2022
B
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
2022-03-08
Mar 8, 2022
A
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Nagoya-shi, Aichi, Japan
  • +19 more
2022-02-18
Feb 18, 2022
U
Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
2022-02-07
Feb 7, 2022
A
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Concord, New South Wales, Australia
  • +30 more
2022-01-31
Jan 31, 2022
E
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
Not yet recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • (no location specified)
2022-01-24
Jan 24, 2022
M
A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML
Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • Duarte, California
  • +10 more
2022-01-18
Jan 18, 2022
N
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
Active, not recruiting
Has Results
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-10
Jan 10, 2022
A
A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
2022-01-12
Jan 12, 2022
M
A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
2021-12-14
Dec 14, 2021
C
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Enrolling by invitation
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
C
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
A
Study Evaluating Venetoclax in Subjects With Hematological Malignancies - 2021
Completed
  • Non-Hodgkin Lymphoma (NHL)
  • +4 more
  • Nagoya shi, Aichi, Japan
  • +13 more
2021-07-29
Jul 29, 2021
A
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
Active, not recruiting
  • Follicular Lymphoma (FL)
  • +12 more
  • Tucson, Arizona
  • +18 more
2021-06-17
Jun 17, 2021
U
Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) - 2014
Withdrawn
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Bendamustine and Rituximab Induction followed by Rituximab and Lenalidomide Maintenance
  • (no location specified)
2019-11-13
Nov 13, 2019
N
Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies
Unknown status
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • Nanjing, Jiangsu, China
  • +1 more
2019-04-27
Apr 27, 2019
G
A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL - 2016
Terminated
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +5 more
2018-10-19
Oct 19, 2018
G
Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - 2011
Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +2 more
2015-03-19
Mar 19, 2015